The Investment Exchange

Welcome to the latest edition of "The Investment Exchange," your premier source for mergers & acquisitions, investment and personal growth insights. In this issue, we bring you the latest deals and opportunities plus introduce some of the podcasters, influencers and content creators that are shaping the investment landscape.  

Contents

1. Weekly Update - A Rollercoaster of a Week…

2. Current Investment Opportunities - CureGBM: Giving Brain Tumour Patients a Fighting Chance

3. Expert Corner - This Week on The Open Equity Show
   How Jeremy Harbour Buys Companies Without Banks, Brokers or Big Capital

4. Events, Offers, Insights and Announcements - Last Chance to Invest at Our Old Valuation – Alphagenix

5. Bonus TRT Protocols with Dr Max Draper, Dr Andrew Winge & Dr Adam Hotchkiss

Section 1 - 🌪️ A Rollercoaster of a Week…

This one’s been wild
2 days in hospital with the infectious disease team, who (hopefully!) are finally starting to unravel the mystery behind my recurring health issues.

Still got a few tubes coming out of places I’d rather they didn’t 😂
…and a fresh round of tests next week to (literally) get to the bottom of it.

But here’s the thing: life doesn’t stop.

Even from a hospital bed, I managed to:
💼 Submit an offer on a seriously exciting business here in Dubai
🏡 Keep moving forward with family conversations about where we want to put down roots next year — balancing health, happiness, and big visions for the future

This week’s reminder?
Progress doesn’t always look pretty.
It’s not always visible.
But it counts.

Business and health aren’t two separate lanes — they’re deeply intertwined.
When you elevate one, the other follows.

Here’s to resilience, clarity, and staying in motion — even when life throws a curveball.

🙏 Thanks to everyone who checked in — I see you and appreciate you more than you know.

🔥 And if you’re on your own journey of health optimisation, conscious leadership, and scaling with certainty — this is exactly why I built Ascend³.

Because life doesn’t wait for perfect timing.
It rewards those who move anyway.

DM me if you're ready to grow — from the inside out.

If you’re an investor, strategic partner, or founder exploring an exit, now is a great time to connect. We’ve got exciting projects at Balmoral Partners and Ascend³ from healthcare to high-growth roll-ups and we’re always looking for the right people to join us on the journey.

P.S. Want to explore a fit? Book a quick 20-min call here: https://calendly.com/the_scale_pyramid/30min

Section 2 - 🎯 CureGBM: Giving Brain Tumour Patients a Fighting Chance

The Problem:
Each year, over 27,000 adults and 250 children in Europe are diagnosed with a brain tumour. Current treatments offer limited survival — just 17% make it to two years — and come with severe, often debilitating side effects. Meanwhile, a promising, non-invasive therapy called Sonodynamic Therapy (SDT) is available in the U.S. — but not in Europe, the Middle East, India, or Singapore.

The CureGBM Solution:
We're bringing this breakthrough treatment to these underserved regions — using a safer, cheaper, and portable SDT device made in the U.S.

• No surgery

• No side effects

• No damage to healthy brain tissue

• Gentle, painless, and non-invasive

Early U.S. studies show a doubling of life expectancy, potentially increasing two-year survival rates by 190%.

The Opportunity:

• Global TAM: 330,000+ new diagnoses annually

• Immediate SAM in our exclusive territory: 56,500+ new patients/year

• Our device costs just $200k vs. $2.8M for competitors

• Treatment cost slashed to £45k/year vs. $200k+

• Portable and MRI-free, enabling anywhere access

We’re commencing clinical trials for European approval now — and plan to expand rapidly across Europe, the Middle East, India, and Singapore.

We’re raising £500k now with 40% already subscribed amd 50k minimum ticket. We will then be raising a further 3.5 Million in 2026.

Join us in transforming brain tumour treatment and giving thousands of patients more time with the people they love.

📧 Richard Wakefield | CEO & Founder
📞 +43 650 410 8330
🌐 www.curegbm.co.uk | 📩 [email protected]

Section 3 - Expert Corner: 🎙️ This Week on The Open Equity Show
How Jeremy Harbour Buys Companies Without Banks, Brokers or Big Capital

I have the pleasure of introducing my friend Thomas Cornwalls Open Equity podcast this week who is interviewing a mentor of mine, Jeremy Harbour

Jeremy Harbour has built and exited dozens of companies, taken multiple businesses public, and trained thousands of dealmakers globally — all without traditional investment banking or needing huge cash up front.

In this episode, we dive into:
🔹 His no-nonsense approach to M&A
🔹 Why most entrepreneurs stay stuck as owner-operators
🔹 The exact deal structures that let you acquire profitable businesses with little or no money down

If you're serious about scaling through acquisition, this is one you don’t want to miss.

🎧 Listen now → https://www.openequity.co.uk

🔥 Want to scale smarter?
Take the free Scale Score test → https://www.openequity.co.uk/the-scale-score

Join the Open Equity newsletter for weekly strategies → https://www.openequity.co.uk/newsletter

We're actively investing. If you're building a great company and want to grow — let’s talk. 🚀

Section 4 - Events, Offers, Insights and Announcements: 🚨 Last Chance to Invest at Our Old Valuation – Alphagenix 🚨

We're closing out the final allocation at our previous valuation of £2.5M, before Alphagenix is officially revalued at £10M+ ,driven by our imminent international expansion and growing momentum in the longevity, regenerative medicine, and men’s health space.

We have a couple of spots left for the right kind of investor, ideally smart money who can bring more than just capital:
✔️ Strategic connections
✔️ Sector expertise
✔️ Alignment with our mission to redefine men’s health and ageing well

📈 This is the last opportunity to come in before we shift gears and valuations.

➡️ Minimum ticket: £25,000
➡️ Targeting partners who want to grow with us, not just invest

If this sounds like you or someone in your network, drop me a message directly or email [email protected].

Let’s build something with real impact.

Onwards and upwards 🚀

Have a great day

Ross

Here are 3 ways we can work together

1. Apply to join our small group accountability program. With a full 12 months to work together, this could just be what you need to supercharge your business growth, raise investment or get started on the business acquisition ladder.

2. Submit a pitch deck or investment proposal to share in an upcoming newsletter

3. Reach out about Joint Venturing, partnering or working with me and the team

You can follow me below

Contact [email protected]

Bonus Section 5

The TRT Protocols Course offers an evidence-based, six-week online program designed to guide men through understanding and optimizing their testosterone levels. Led by experienced physicians specializing in men's health and hormone optimization, the course provides:

• Week 1: Foundations of testosterone and its impact on overall health.

• Week 2: Interpreting lab results and understanding hormonal imbalances.

• Week 3: Natural methods to enhance testosterone production.

• Week 4: Introduction to testosterone replacement therapy (TRT) and its protocols.

• Week 5: Advanced TRT strategies and monitoring.

• Week 6: Integrating lifestyle changes for sustained hormonal health.

This course is ideal for individuals seeking to take control of their hormonal health, offering practical knowledge without the need for prior medical expertise. For more information and to enrol, visit TRT Fundamentals.

Happy investing!

Ross and The Investment Exchange Team

We hope you find this edition of "The Investment Exchange" informative and valuable. Your feedback and suggestions are important to us, so please feel free to reach out to us with any comments or ideas for future editions.

Note: This content is intended for informational purposes only and does not constitute financial advice. Please consult with a professional advisor before making any investment de